PE anti-human HLA-A,B,C [W6/32] and 2 more items

The University of Virginia issued contract A207_PO-0450285 to BioLegend Inc., a prime contractor, on June 19, 2026, for the procurement of specialized laboratory reagents valued at $707. The awarded contract encompasses three distinct fluorescently-labeled monoclonal antibody products for human immunological applications, all designated for delivery to Abhinav Arneja at the University of Virginia. The line items include PE anti-human Human Leukocyte Antigen-A,B,C [W6/32] at $151.20 per unit, Alexa Fluor 647 anti-human Human Leukocyte Antigen-DR, DP, DQ [Tu39] at $254.80 per unit, and Brilliant Violet 421 anti-human CD14 [63D3] at $301.50 per unit, with one unit of each product ordered.

This contract award represents a routine procurement of flow cytometry reagents necessary for immunological research and analysis at the University of Virginia. The biological reagents supplied under this agreement are essential laboratory tools used in the identification and characterization of human immune cells through fluorescent labeling techniques. As a state and local contract issued by a Virginia-based public institution, this procurement falls within standard research supply acquisitions conducted by academic medical centers and research universities throughout Virginia.